Global football superstar Cristiano Ronaldo has made a notable business move by investing $7.5 million in a technology subsidiary of Herbalife Ltd., a leading nutrition and wellness company with which he has had a long-standing partnership. The investment, which grants him a 10 percent equity stake in HBL Pro2col Software LLC, was announced alongside Herbalife’s latest financial results and has sparked a significant response from financial markets and investors.
Ronaldo’s investment reflects both his personal commitment to health and nutrition and his confidence in the growing importance of personalised wellness technologies. HBL Pro2col Software, LLC owns Pro2col, a digital health and wellness platform developed by Herbalife that uses data analytics and user information to create tailored nutrition and lifestyle plans aimed at encouraging healthier habits and measurable outcomes. The software is designed to engage users daily, combining structured health insights with scalable digital tools for engagement across global markets.
The announcement came as part of Herbalife’s fourth quarter earnings report, which showed a modest 1 percent increase in full year 2025 sales compared to the previous year and a 6.3 percent jump in fourth quarter revenue. The reported financial performance, paired with Ronaldo’s investment, triggered a surge in Herbalife’s stock price, with shares climbing by more than 15 percent in early trading following the news. This immediate market reaction reflected investor enthusiasm about Ronaldo’s backing of the company’s future direction and its potential to harness digital health technology for growth.
A strategic evolution of a long-term partnership
Cristiano Ronaldo’s relationship with Herbalife spans more than a decade, beginning in 2013 when he signed on as a global brand ambassador and official nutrition partner. Over the years, this partnership has involved a range of collaborative initiatives, including the launch of Herbalife24 CR7 Drive, a co-branded sports drink formulated with Ronaldo’s input and marketed to athletes and fitness enthusiasts worldwide. Although Ronaldo has been featured in global advertising campaigns for Herbalife, his public investment in Pro2col marks the first time he has taken an ownership position in the company itself.
In a statement shared by Herbalife, Ronaldo described his investment as a natural evolution of the long-standing partnership. He emphasised that his involvement in Pro2col goes beyond a traditional sponsorship deal, signaling a deeper commitment to shaping the future of personalised health technology and encouraging healthier lifestyles on a global scale.
Herbalife’s CEO, Stephan Gratziani, highlighted that Ronaldo’s decision to take an equity stake in Pro2col is a milestone in their relationship, reinforcing a shared belief in nutrition, data driven wellness solutions, and the potential of personalized insights to deliver better health outcomes. Gratziani noted that the investment aligns with Herbalife’s broader ambition to integrate innovative technology and community support to expand its wellness platforms worldwide.
Pro2col’s role in herbalife’s future growth
Pro2col represents Herbalife’s next generation approach to health and nutrition technology. The platform is designed to collect individual health and lifestyle data, use proprietary scoring systems such as Pro2Score to track progress across key wellness metrics, and provide customised recommendations and daily habit tracking. By integrating AI capabilities and data insights, Pro2col aims to enhance user engagement and drive sustainable behavior change.
As part of its rollout strategy, Herbalife has initiated a strategic beta release of Pro2col technology, initially offering access to distributors and customers in the United States, Canada, and Puerto Rico. The company plans to expand beta access to select Europe, Middle East and Africa markets later in 2026, ahead of a broader commercial launch. This phased approach reflects Herbalife’s intent to refine the platform through real world insights and build momentum ahead of further global expansion.
Market and personal implications
Ronaldo’s investment comes at a time when he continues to be one of the highest paid and most influential athletes in the world. According to recent rankings, he topped Forbes’ 2025 list of highest paid footballers, with total earnings of approximately $280 million, a significant portion of which comes from off field ventures, including his CR7 brand hotels, fitness facilities, product lines, and substantial social media influence. His personal brand and global reach estimated to span over 1 billion followers across platforms make his endorsement and investment particularly impactful for Herbalife’s visibility and market perception.
At 41, Ronaldo is also preparing to represent his home country, Portugal, in the 2026 World Cup, where he is set to be among the oldest players competing and is seeking personal milestones in his decorated career. His business activities, including the Pro2col investment, highlight a strategic pivot toward leveraging his stature and influence to back innovative ventures that resonate with his long-standing commitment to health, performance, and excellence.
In summary, Ronaldo’s $7.5 million investment in Pro2col technology marks a significant step not only in his partnership with Herbalife but also in the company’s efforts to redefine personalised health and wellness through data driven digital platforms. The stock surge and market reaction underscore the confidence that investors and the broader health tech industry have in both Ronaldo as an influential investor and Herbalife’s strategic direction in wellness innovation.